The effect of remdesivir as an anti-covid-19 drug on the secretion of inflammatory markers by chicken hepatocytes: an in vitro study

Zahra Akbari Jonoush; Roya Mahdavi; Mehri Ghafourian; Seyed Esmaeil Khoshnam; Fereshteh Nezhad Dehbashi; Maryam Farzaneh

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

The effect of remdesivir as an anti-covid-19 drug on the secretion of inflammatory markers by chicken hepatocytes: an in vitro study

Author(s):

Zahra Akbari Jonoush¹,

Roya Mahdavi²,

Mehri Ghafourian³,

Seyed Esmaeil Khoshnam⁴,

Fereshteh Nezhad Dehbashi⁵,

Maryam Farzaneh^6,*

1Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

2Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

3Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

5Cellular and Molecular Research Center, Medical Basic Science Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

6Fertility, Infertility, and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Journal of Inflammatory Diseases:Vol. 26, issue 4; 173-182

Published online:Mar 31, 2023

Article type:Research Article

How to Cite:Akbari Jonoush Z, Mahdavi R, Ghafourian M, Khoshnam SE, Dehbashi FN, et al. The effect of remdesivir as an anti-covid-19 drug on the secretion of inflammatory markers by chicken hepatocytes: an in vitro study. J Inflamm Dis. 2024;26(4):e156324. doi:

Abstract

Background: For severe cases of acute respiratory syndrome type 2 (SARS-CoV-2) infection (COVID-19), Remdesivir (RDV) is introduced as an anti-viral drug with side effects. Hepatotoxicity from prolonged exposure to RDV is associated with increased inflammatory factors. In this study, we evaluated the effect of RDV on the secretion of inflammatory markers by chicken liver cells. Methods: In this in vitro study, 20 stage X embryonated chicken eggs were incubated for 10 days at 37.5°C and 60–65% humidity Hamburger–Hamilton stages (stage HH35). Liver cells were grown in a medium containing DMEM/F12+10% fetal bovine serum (FBS). After three days, the culture media was supplemented with four doses of RDV (1.00, 2.00, 3.00, and 4.00 μM). After 24 and 48hs, the viability of the hepatocytes, gene expression of Sox17, CXC motif chemokine receptor 4 (CXCR4), Interleukin-1 (IL-1), Interleukin-6 (IL-6), and TNF-α, and hepatocellular functions (albumin and urea secretion) were assessed. Findings: Each hepatocyte had a prominent nucleus and a nucleolus with a hexagonal shape. The pink tint of the periodic acid Schiff (PAS) positive cells in the PAS staining verified the hepatocytes’ glycogen content. Up to 50% of the cells lose viability after 48 hours in the presence of 3 and 4 μM RDV (P<0.001). In the presence of 3 μM RDV, the production and secretion of both albumin (P<0.001) and urea (P<0.05) decreased. Besides, the expression of IL-1, IL-6, and TNF-α significantly increased after treatment with 3 μM RDV (P<0.001). Conclusion: We concluded that RDV therapy altered the expression and function of hepatocyte inflammatory factors.

Keywords

Role of COVID-19 in Hepatic Damage and Its Cellular Entrance and Mechanism of Action: A Mini-Review

Ali Akbar Oroojan

Oroojan AA. Role of COVID-19 in Hepatic Damage and Its Cellular Entrance and Mechanism of Action: A Mini-Review. J Adv Immunopharmacol. 2021;1(1):e113644. doi: https://doi.org/10.5812/tms.113644

6

Apr

2020

Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients

Versa Omrani-Nava,

Iradj Maleki,

Abdolrahim Ahmadi,

Mahmood Moosazadeh,

Akbar Hedayatizadeh-Omran,

Fatemeh Roozbeh

,et al.

Omrani-Nava V, Maleki I, Ahmadi A, Moosazadeh M, Hedayatizadeh-Omran A, et al. Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients. Hepat Mon. 2020;20(4):e103179. doi: https://doi.org/10.5812/hepatmon.103179

11

Aug

2025

Inhibition of Inflammatory Signals “HMGB1, NLRP3, TNF-α, IL-1β” and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of Dracocephalum kotschyi

Maryam Karimi-Dehkordi,

Firoozeh Saghaei,

Erfan Hoseini

Karimi-Dehkordi M, Saghaei F, Hoseini E. Inhibition of Inflammatory Signals “HMGB1, NLRP3, TNF-α, IL-1β” and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of Dracocephalum kotschyi. Iran J Pharm Res. 2025;24(1):e162656. doi: https://doi.org/10.5812/ijpr-162656

4

Dec

2021

Evaluation of Liver Enzyme Levels in Patients with SARS-CoV-2 Infection

Alireza Janbakhsh,

Zahra Naghibifar,

Sodabeh Eskandari,

Zeinab Mohseniafshar,

Maria Shirvani,

Mohammad Hossein Zamanian

,et al.

Janbakhsh A, Naghibifar Z, Eskandari S, Mohseniafshar Z, Shirvani M, et al. Evaluation of Liver Enzyme Levels in Patients with SARS-CoV-2 Infection. J Kermanshah Univ Med Sci. 2021;25(4):e116744. doi: https://doi.org/10.5812/jkums.116744

22

Dec

2020

Liver Enzymes and Inpatient Deaths in COVID-19 Hospitalized Patients

Mahmoodreza Khoonsari,

Farhad Zamani,

Mohammad Hadi Karbalaie Niya,

Gholamreza Hemmasi,

Hossein Ajdarkosh,

Amirhossein Faraji

,et al.

Khoonsari M, Zamani F, Karbalaie Niya MH, Hemmasi G, Ajdarkosh H, et al. Liver Enzymes and Inpatient Deaths in COVID-19 Hospitalized Patients. Hepat Mon. 2020;20(11):e109076. doi: https://doi.org/10.5812/hepatmon.109076

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 3 days ago
Scopus by Title: 0
Last Update: 3 days ago
Scopus by Title (Ref): 0
Last Update: 3 days ago
CrossRef: 0
Last Update: 1 day ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Zahra Akbari Jonoush:[PubMed][Scholar]
Roya Mahdavi:[PubMed][Scholar]
Mehri Ghafourian:[PubMed][Scholar]
Seyed Esmaeil Khoshnam:[PubMed][Scholar]
Fereshteh Nezhad Dehbashi:[PubMed][Scholar]
Maryam Farzaneh:[PubMed][Scholar]

The Official Journal of Qazvin University of Medical Sciences

Outlines

The effect of remdesivir as an anti-covid-19 drug on the secretion of inflammatory markers by chicken hepatocytes: an in vitro study

Abstract

Similar Articles

Role of COVID-19 in Hepatic Damage and Its Cellular Entrance and Mechanism of Action: A Mini-Review

Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients

Inhibition of Inflammatory Signals “HMGB1, NLRP3, TNF-α, IL-1β” and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of Dracocephalum kotschyi

Evaluation of Liver Enzyme Levels in Patients with SARS-CoV-2 Infection

Liver Enzymes and Inpatient Deaths in COVID-19 Hospitalized Patients

Last Update: 3 days ago

Last Update: 3 days ago

Last Update: 3 days ago

Last Update: 1 day ago